NCT06712654: A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
- State
- Under way
- Phase
- Phase 2
- People
- 168 planned
- Started
- 1 Jun 2026
- Primary completion
- 28 Feb 2027
- Arms
- Cohort 2
- Results
- None posted
- 2 Dec 2024: Trial registered
- 1 Jun 2026: Trial started